Clinical Trials Directory

Trials / Completed

CompletedNCT02112955

A Self-efficacy Enhancing Stroke Self-management Program for Community-dwelling Stroke Survivors

A Randomized Controlled Trial of the Effectiveness of a Nurse-led Self-efficacy Enhancing Stroke Self-management Program for Community-dwelling Stroke Survivors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
128 (actual)
Sponsor
Queensland University of Technology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to examine the effectiveness of a nurse-led self-efficacy enhancing stroke self-management program on recovery of community-dwelling stroke survivors.

Detailed description

Previous systematic reviews showed that theory-based stroke self-management programs had potential benefits in improving stroke survivors' quality of life and self-efficacy. However there is a lack of evidence evaluating the effectiveness of a nurse-led theory-based stroke self-management program among community-dwelling Chinese stroke survivors. This is a parallel group, single-blinded, randomized controlled trial to be held in a community center. All participants will be assessed at two time-points (baseline before randomization, and one month after program completion). Eligible participants will be randomly allocated to either the control group (receiving usual care) or the intervention group (receiving the self-efficacy enhancing stroke self-management program). Participants in the intervention group will receive an additional assessment on usefulness of the program immediately after program completion.

Conditions

Interventions

TypeNameDescription
BEHAVIORALStroke self-management programA nurse-led community-based self-efficacy enhancing stroke self-management program.
BEHAVIORALUsual careUsual care such as hospital-based or community-based health education or services.

Timeline

Start date
2014-05-01
Primary completion
2016-01-01
Completion
2016-05-01
First posted
2014-04-14
Last updated
2016-11-09

Locations

3 sites across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT02112955. Inclusion in this directory is not an endorsement.